Showing results (231-240 of 306) with videos related to
Sort By:
Pageof 31
Genomics|January 27, 1998
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1J Harder, R Siebert, Y Zhang, et al.Biochemical and Biophysical Research Communications|August 23, 1996
Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variantsJ Bartels, C Schlüter, E Richter, et al.Archives of Dermatological Research|January 1, 1983
Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?A Langner, T P Chorzelski, M Fraczykowska, et al.Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1989
Effects of psoriatic patients' neutrophils and sera on angiogenic capability and natural cytotoxicity of normal human peripheral blood mononuclear cellsS Majewski, M Wasik, S Jabłońska, et al.The British Journal of Dermatology|August 15, 2001
Long-term safety of topical calcitriol 3 microg g(-1) ointmentM J Gerritsen, P C Van De Kerkhof, A LangnerThe British Journal of Dermatology|June 1, 1985
The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophilsS Majewski, S Jabłonska, A Langner, et al.Deutsche Medizinische Wochenschrift (1946)|September 6, 1996
[Cryofibrinogenemia caused by monoclonal anti-fibrinogen antibodies]R A Zeuner, R Béress, J O Schröder, et al.The British Journal of Dermatology|September 1, 1996
A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasisA Langner, P Ashton, P C Van De Kerkhof, et al.Fundamental & Clinical Pharmacology|January 1, 1989
Pharmacological modulation of neurogenic inflammationH H Schumann, A Langner, R Rathsack, et al.Archives of Dermatology|February 1, 1994
The genetics of psoriasisJ T Elder, R P Nair, S W Guo, et al.Pageof 31